Identification Of Drug Related Problems In Chronic Kidney Disease With Sufferers Of Anemia In Inpatient Installations At H. Adam Malik Medan Central General Hospital

by ADMIN 166 views

Identification of Drug-Related Problems in Chronic Kidney Disease with Sufferers of Anemia in Inpatient Installations at H. Adam Malik Medan Central General Hospital

Introduction

In the world of health, one of the significant challenges faced by many patients is a problem related to drugs or drug-related problems (DRPS). DRPS refers to unwanted events experienced by patients related to drug therapy, both real and potentially affecting the desired treatment results. This case becomes increasingly complex in the context of chronic kidney disease (PGK), which is now considered a serious global health problem, especially when patients also experience anemia. Chronic kidney disease can cause various complications, including the need to start treatment with a lot of drugs (polypharmacy). This places patients at high risk of the occurrence of DRPS which can affect their quality of life.

Background

Chronic kidney disease is a serious global health problem that affects millions of people worldwide. It is characterized by a gradual loss of kidney function over time, which can lead to various complications, including anemia. Anemia is a condition where the body does not have enough red blood cells or hemoglobin, which can cause fatigue, weakness, and shortness of breath. The management of chronic kidney disease and anemia requires a multidisciplinary approach, including the use of various medications. However, the use of multiple medications can increase the risk of drug-related problems (DRPS).

Methodology

This study aims to determine the rate of DRPS in PGK patients who also suffer from anemia, by analyzing 20 patients at the Inpatient Installation of H. Adam Malik Hospital Medan. The method used in this study is the strand method, which divides the DRPS category into seven types: indications without drugs, drugs without indications, improper drugs, lack of drug doses, excess drug doses, adverse drug reactions, and drug interactions. Data collection was carried out prospectively, by examining the medical records of patients treated at the hospital between December 2015 and February 2016.

Results

The results of research involving 20 patients showed that 19 out of 20 patients (95%) experienced DRPS. The most common type of DRPS found is indications without drugs with 26 cases (61.91%), followed by drug interactions with 15 cases (35.71%), and drugs without indications with 1 case (2.38%).

Discussion

The high number of DRPS events in PGK patients suffering from anemia shows that there are significant problems in managing drug therapy for these patients. This finding underlines the importance of evaluating and monitoring that is tighter about the treatment given to patients, to prevent further complications and improve their quality of life. The most commonly found DRPS, namely indications without drugs, can be caused by a lack of communication between health workers regarding patient therapy needs or incompleteness in determining indications. This shows the need for better training for health workers in recognizing and handling the needs of patients with PGK and anemia, as well as the importance of strengthening the medical documentation system to ensure that all aspects of patient treatment have been calculated.

Conclusion

Overall, this study confirms that the management of drug therapy for PGK patients with anemia needs more attention. Emphasis on collaboration between health workers, including doctors, nurses, and pharmacists, will be very helpful in preventing DRPS and increasing therapy results for patients. Thus, the quality of health care can be increased and the complexity of the disease suffered by patients can be minimized.

Recommendations

Based on the findings of this study, the following recommendations are made:

  1. Improved communication between health workers regarding patient therapy needs.
  2. Better training for health workers in recognizing and handling the needs of patients with PGK and anemia.
  3. Strengthening the medical documentation system to ensure that all aspects of patient treatment have been calculated.
  4. Regular evaluation and monitoring of drug therapy for PGK patients with anemia.
  5. Collaboration between health workers, including doctors, nurses, and pharmacists, to prevent DRPS and increase therapy results for patients.

Limitations

This study has several limitations, including:

  1. Small sample size: The study only analyzed 20 patients, which may not be representative of the larger population.
  2. Limited data collection: The study only collected data from medical records, which may not provide a comprehensive picture of the patients' experiences.
  3. Lack of control group: The study did not have a control group, which makes it difficult to compare the results with a group of patients who did not experience DRPS.

Future Research Directions

Future research should focus on:

  1. Large-scale studies: Conducting larger-scale studies to confirm the findings of this study.
  2. Longitudinal studies: Conducting longitudinal studies to examine the long-term effects of DRPS on patients with PGK and anemia.
  3. Qualitative studies: Conducting qualitative studies to gain a deeper understanding of the experiences of patients with PGK and anemia who experience DRPS.
    Frequently Asked Questions (FAQs) about Drug-Related Problems in Chronic Kidney Disease with Sufferers of Anemia

Q: What is drug-related problem (DRPS)?

A: DRPS refers to unwanted events experienced by patients related to drug therapy, both real and potentially affecting the desired treatment results.

Q: What is chronic kidney disease (PGK)?

A: PGK is a serious global health problem that affects millions of people worldwide. It is characterized by a gradual loss of kidney function over time, which can lead to various complications, including anemia.

Q: What is anemia?

A: Anemia is a condition where the body does not have enough red blood cells or hemoglobin, which can cause fatigue, weakness, and shortness of breath.

Q: What are the common types of DRPS in PGK patients with anemia?

A: The most common types of DRPS found in this study are indications without drugs, drug interactions, and drugs without indications.

Q: What are the causes of DRPS in PGK patients with anemia?

A: The causes of DRPS in PGK patients with anemia include a lack of communication between health workers regarding patient therapy needs, incompleteness in determining indications, and the use of multiple medications.

Q: How can DRPS be prevented in PGK patients with anemia?

A: DRPS can be prevented in PGK patients with anemia by improving communication between health workers, providing better training for health workers in recognizing and handling the needs of patients with PGK and anemia, and strengthening the medical documentation system.

Q: What is the role of pharmacists in preventing DRPS in PGK patients with anemia?

A: Pharmacists play a crucial role in preventing DRPS in PGK patients with anemia by evaluating drug interactions regularly and thoroughly before prescribing drugs.

Q: What are the implications of DRPS in PGK patients with anemia?

A: The implications of DRPS in PGK patients with anemia include the need for tighter evaluation and monitoring of treatment, the importance of collaboration between health workers, and the need for better training for health workers.

Q: What are the recommendations for managing DRPS in PGK patients with anemia?

A: The recommendations for managing DRPS in PGK patients with anemia include improved communication between health workers, better training for health workers, strengthening the medical documentation system, regular evaluation and monitoring of drug therapy, and collaboration between health workers.

Q: What are the limitations of this study?

A: The limitations of this study include a small sample size, limited data collection, and the lack of a control group.

Q: What are the future research directions for DRPS in PGK patients with anemia?

A: The future research directions for DRPS in PGK patients with anemia include large-scale studies, longitudinal studies, and qualitative studies to gain a deeper understanding of the experiences of patients with PGK and anemia who experience DRPS.

Q: What are the implications of this study for healthcare providers?

A: The implications of this study for healthcare providers include the need to improve communication between health workers, provide better training for health workers, and strengthen the medical documentation system to prevent DRPS in PGK patients with anemia.

Q: What are the implications of this study for patients with PGK and anemia?

A: The implications of this study for patients with PGK and anemia include the need for tighter evaluation and monitoring of treatment, the importance of collaboration between health workers, and the need for better training for health workers to prevent DRPS.